An Experimental Medicine multicenter Trial to evaluate the safety and immunogenicity of experimental versus
authorized SARS-CoV-2 vaccine candidates as a booster dose in healthy participants previously vaccinated with
authorized mRNA SARS-CoV-2 vaccines.
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.